![Michael K. McGarrity](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael K. McGarrity
Chief Executive Officer at MDXHEALTH SA
Net worth: - $ as of 2024-06-29
Michael K. McGarrity active positions
Companies | Position | Start | End |
---|---|---|---|
MDXHEALTH SA | Director/Board Member | 2019-02-17 | - |
Chief Executive Officer | 2019-02-17 | - | |
LeviSense Medical, Inc. | Chairman | - | - |
MDxHealth, Inc.
![]() MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Career history of Michael K. McGarrity
Former positions of Michael K. McGarrity
Companies | Position | Start | End |
---|---|---|---|
Sterilis Solutions, LLC
![]() Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Chief Executive Officer | 2017-05-31 | 2017-12-31 |
NANOSPHERE, INC. | Director/Board Member | 2013-02-18 | 2016-08-31 |
Chief Executive Officer | 2013-02-12 | 2016-08-31 | |
President | 2013-02-12 | 2016-08-31 | |
Sales & Marketing | 2005-08-31 | 2012-12-31 | |
STRYKER CORPORATION | Sales & Marketing | 1992-12-31 | 2004-12-31 |
Training of Michael K. McGarrity
University of Notre Dame | Undergraduate Degree |
Statistics
International
United States | 7 |
Belgium | 2 |
Operational
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Sales & Marketing | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
MDXHEALTH SA | Health Technology |
Private companies | 4 |
---|---|
Nanosphere, Inc.
![]() Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
Sterilis Solutions, LLC
![]() Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Health Technology |
LeviSense Medical, Inc. | |
MDxHealth, Inc.
![]() MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Health Technology |
- Stock Market
- Insiders
- Michael K. McGarrity
- Experience